Method of accelerating the proliferation of emdothelial cells wi

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 12, A61K 31175, A61K 31165, A61K 3112

Patent

active

054788218

ABSTRACT:
A method of accelerating the proliferation of endothelial cells with inhibition of NO synthases in warm-blooded animals comprising administering to warm-blooded animals an amount of at least one compound selected from the group consisting of a .beta.-naphthoquinone of the formula ##STR1## wherein R is selected from the group consisting of --NH--CO--NH.sub.2, --NH--C0--CH.sub.3 and --0H and their non-toxic, pharmaceutically acceptable acid addition salts in an amount sufficient to accelerate the proliferation of endothelial cells.

REFERENCES:
patent: 3758520 (1973-09-01), Beaudet
M. Ploin, "Etioven 10 mg., Medicament De L'annee", La Gazette Medicale, vol. 100, No. 20, p. 30, May 1993.
Laborit et al, "Effets de la Mono-Semicarbazone . . . Hemorragique Experimental", Agressologie, vol. 12, pp. 25-30, (1971).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of accelerating the proliferation of emdothelial cells wi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of accelerating the proliferation of emdothelial cells wi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of accelerating the proliferation of emdothelial cells wi will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1369306

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.